Syngene International Limited

NSE: SYNGENE

Healthcare Healthcare

₹397.5

+2.95%EOD · 19 Oct

Syngene International Limited is a listed Healthcare company on NSE/BSE. Detailed profile data is being compiled — check BSE filings for the latest disclosures.

Market Cap

₹15,976 Cr

52W Range

₹679 / ₹344

Volume

1710K

45.5% delivery

1Y Return

-39.0%

P/E Ratio

70.3

P/B Ratio

3.2

ROE

6.6%

Debt / Equity

9.47

Peers in Healthcare

Top 8 by market cap

Company	LTP	Market Cap	P/E	P/B	ROE %	Div Yld %
Syngene International Limited(this stock)	₹397.5	₹15,976 Cr	70.3	3.2	6.6%	0.33%
Divi's Laboratories LimitedDIVISLAB	₹9,087	₹2.41 L Cr	83.0	14.5	16.2%	0.33%
Torrent Pharmaceuticals LimitedTORNTPHARM	₹4,558.7	₹1.73 L Cr	72.8	18.4	17.0%	0.83%
Laurus Labs LimitedLAURUSLABS	₹2,069	₹1.12 L Cr	101.8	21.0	17.7%	0.12%
Zydus Lifesciences LimitedZYDUSLIFE	₹1,113.9	₹1.11 L Cr	25.0	4.2	18.3%	0.09%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP	₹7,700	₹1.11 L Cr	54.3	12.0	21.5%	0.25%
Aurobindo Pharma LimitedAUROPHARMA	₹1,621.4	₹93,292 Cr	26.1	2.6	9.9%	0.00%
Mankind Pharma LimitedMANKIND	₹2,253.2	₹93,067 Cr	46.0	5.8	12.4%	0.00%
Max Healthcare Institute LimitedMAXHEALTH	₹830	₹80,785 Cr	56.7	7.7	14.3%	0.23%

Quality Score

Durability · Valuation · Momentum — objective math, not advice

28/100

Composite score: 40% quality, 30% valuation, 30% momentum

QualityWeak · 35

ValuationPoor · 20

MomentumWeak · 25

High debt load (D/E 9.5)

In confirmed downtrend (Stage 4)

Very expensive valuation (P/E 70x)

Technical Indicators

Full analysis · objective math, not advice

Returns

+3.0%

+6.9%

+4.6%

-4.8%

-9.0%

-39.0%

Weinstein Stage

Stage 4 — Declining (downtrend)

RSI (14)

60 Neutral

Trend Template

1/7weak

RS vs Nifty (3M)

+0.7pp

Moving Averages (price vs MA)

20-DMA

₹373

above

50-DMA

₹387

above

150-DMA

₹416

below

200-DMA

₹441

below

From 52W High

-41.5%

From 52W Low

+15.4%

Support (20D)

₹344

Resistance (20D)

₹402

Technical indicators are objective calculations from historical EOD prices (RSI, moving averages, Weinstein stage, Minervini trend-template, relative strength). For educational reference only — not a buy/sell recommendation.

News & FilingsGoogle News + BSE

News via Google News · Not verified by IPOpulse · Not investment advice

Community discussion(0)

No comments yet — be the first to share your view.